ASTHMA-TREATMENT - A NEGLECTED OPTION

[1] [Anonymous], 1960, ANN RHEUM DIS, V19, P95

[2] Burns Amberson J., 1931, AM REV TUBERC, V24, P401

[3] DAVIS P, 1979, J RHEUMATOL, V6, P1

[4] Forestier J, 1934, LANCET, V2, P646

[5] MCCORMICK J, 1980, AM REV RESPIR DIS, V122, P145

[6] BRONCHIAL REACTIVITIES TO ACETYLCHOLINE AND IGE LEVELS IN ASTHMATIC SUBJECTS AFTER LONG-TERM REMISSIONS [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1974, 54 (01) : 32 - 40

[7] MURANAKA M, 1978, ANN ALLERGY, V40, P132

[8] GOLD THERAPY - DERMATOLOGIC USES AND TOXICITIES [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1979, 1 (04) : 315 - 320

[9] WELLS H, 1932, CHEM TUBERCULOSIS, P426

[10] 1979, BRIT MED J, V1, P289

[1] [Anonymous], 1960, ANN RHEUM DIS, V19, P95

[2] Burns Amberson J., 1931, AM REV TUBERC, V24, P401

[3] DAVIS P, 1979, J RHEUMATOL, V6, P1

[4] Forestier J, 1934, LANCET, V2, P646

[5] MCCORMICK J, 1980, AM REV RESPIR DIS, V122, P145

[6] BRONCHIAL REACTIVITIES TO ACETYLCHOLINE AND IGE LEVELS IN ASTHMATIC SUBJECTS AFTER LONG-TERM REMISSIONS [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1974, 54 (01) : 32 - 40

[7] MURANAKA M, 1978, ANN ALLERGY, V40, P132

[8] GOLD THERAPY - DERMATOLOGIC USES AND TOXICITIES [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1979, 1 (04) : 315 - 320

[9] WELLS H, 1932, CHEM TUBERCULOSIS, P426

[10] 1979, BRIT MED J, V1, P289